India has extended price caps for drugs including two antibiotics. Government is planning to provide medicine in affordable price.
The National Pharmaceutical Pricing Authority (NPPA) have put caps on prices of 250 mg strength of ciprofloxacin hydrochloride and the 250 mg and 500 mg strengths of cefotaxime. Definitely, Price caps benefit high-income patients rather than the low-income patients & it will also decrease the margin profit of small scale pharma companies.